Ionis Pharmaceuticals (IONS) PT Raised to $72 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Jay Olson raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $72.00 (from $65.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
